Cargando…

Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer

Detalles Bibliográficos
Autores principales: Pocha, Pauline Viviane, Xie, Chencheng, Pocha, Christine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859795/
https://www.ncbi.nlm.nih.gov/pubmed/33553295
http://dx.doi.org/10.21037/atm-20-7534
_version_ 1783646813672177664
author Pocha, Pauline Viviane
Xie, Chencheng
Pocha, Christine
author_facet Pocha, Pauline Viviane
Xie, Chencheng
Pocha, Christine
author_sort Pocha, Pauline Viviane
collection PubMed
description
format Online
Article
Text
id pubmed-7859795
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-78597952021-02-05 Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer Pocha, Pauline Viviane Xie, Chencheng Pocha, Christine Ann Transl Med Editorial AME Publishing Company 2021-01 /pmc/articles/PMC7859795/ /pubmed/33553295 http://dx.doi.org/10.21037/atm-20-7534 Text en 2021 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Editorial
Pocha, Pauline Viviane
Xie, Chencheng
Pocha, Christine
Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
title Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
title_full Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
title_fullStr Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
title_full_unstemmed Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
title_short Addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
title_sort addition of apatinib to transarterial chemoembolization leads to improved outcome in patients with intermediate and advanced hepatocellular cancer
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859795/
https://www.ncbi.nlm.nih.gov/pubmed/33553295
http://dx.doi.org/10.21037/atm-20-7534
work_keys_str_mv AT pochapaulineviviane additionofapatinibtotransarterialchemoembolizationleadstoimprovedoutcomeinpatientswithintermediateandadvancedhepatocellularcancer
AT xiechencheng additionofapatinibtotransarterialchemoembolizationleadstoimprovedoutcomeinpatientswithintermediateandadvancedhepatocellularcancer
AT pochachristine additionofapatinibtotransarterialchemoembolizationleadstoimprovedoutcomeinpatientswithintermediateandadvancedhepatocellularcancer